Yahoo Search Búsqueda en la Web

Resultado de búsqueda

  1. Hace 3 días · The team evaluated a new drug for enhancing the brain’s resilience to changes driven by Alzheimer’s, showing promising results for patients with mild to moderate forms of the disease in its first human trial. The drug LM11A-31, developed by Stanford professor Dr. Frank Longo and UCSF professor Dr. Stephen Massa, targets the P75 neurotrophin ...

  2. Hace 1 día · AI Speeds Up Drug Design for Parkinson's by Ten-Fold. Apr. 17, 2024 — Researchers have used artificial intelligence techniques to massively accelerate the search for Parkinson's disease ...

  3. Hace 4 días · Although the trial's primary purpose was to evaluate the safety and tolerability of the drug in patients with mild to moderate Alzheimer's, researchers also collected multiple markers of brain ...

  4. Hace 4 días · Summary: New data from a phase 2A study presented at the XXIX World Congress indicates that BioVie Inc’s investigational drug bezisterim may enhance sleep, reduce fatigue, and alleviate restless leg symptoms in Parkinsons disease patients when used with levodopa therapy.

  5. Hace 5 días · During DBS surgery, a surgeon implants one or more small wires into the deep part of the brain. The implanted wires are then tunneled beneath the skin to a pulse generating battery in your chest just below the collar bone. This device is like a pacemaker, but for your brain. Once the wires and battery are implanted and turned on, the battery ...

  6. Hace 5 días · The team evaluated a new drug for enhancing the brain’s resilience to changes driven by Alzheimer’s, showing promising results for patients with mild to moderate forms of the disease in its first human trial. The drug LM11A-31, developed by Stanford professor Dr. Frank Longo and UCSF professor Dr. Stephen Massa, targets the P75 neurotrophin ...

  7. Hace 4 días · Trials of alteplase, also called tPA, were pioneered at the University of Cincinnati in the late 1980s, representing the first proven treatment for ischemic stroke. TNK is a more recently developed clot-busting drug that can be administered in a single IV injection within seconds. Some researchers at the conference said the new trial data ...